$1,511,827 awarded to research since 1985
Schizophrenia is a serious mental illness that inhibits a person’s ability to think clearly, recognize reality, interact with others, and manage emotions. Symptoms can include hallucinations, delusions, hearing voices, flat emotional expression, and disorganized or obsessive thinking. While the disease isn’t common, it still affects 3.2 million Americans, and can have devastating consequences for a sufferer’s ability to keep a job or maintain interpersonal relationships. Despite its relative lack of prevalence, its severity and high mortality rate makes schizophrenia the Foundation’s second most highly funded area of study, after depression.
Probing Gene-environment Interactions in Schizophrenia and Stress: Integrating human GWAS and mouse models | McElligott | $60,000
Probing Gene-environment Interactions in Schizophrenia and Stress: Integrating human GWAS and mouse models 2020 Award: $60,000 Schizophrenia is a heritable disorder that is impacted by environmental influences like stressful life experience. Studies have demonstrated thousands [...]
Dissection of Top-down Cortical Circuits Underlying Auditory Oddball Response, a Biomarker for Schizophrenia | Kato | $40,000
Dissection of Top-down Cortical Circuits Underlying Auditory Oddball Response, a Biomarker for Schizophrenia 2020 Award: $40,000 Hallucination, or “hearing voices” is one of the most prevalent symptoms of schizophrenia. In this project we will [...]
Establishing Network Targets during Development for Non-Invasive Brain Stimulation 2016 Award: $37,549 There is some evidence to suggest that directly stimulating the brain with a targeted, low-level electrical current may yield positive effects on [...]
Randomized controlled trial of pyridoxine for tardive dyskinesia 2017 Award: $99,900 To date, the only effective medications to treat the symptoms associated with schizophrenia are the “antipsychotic” class of medications. Unfortunately, these medications have [...]